Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200126334> ?p ?o ?g. }
- W4200126334 endingPage "50" @default.
- W4200126334 startingPage "35" @default.
- W4200126334 abstract "Pharmacogenomics is universally relevant for worldwide modern therapeutics and yet needs further development in resource-limited countries. While there is an abundance of genetic association studies in controlled medical settings, there is a paucity of studies with a naturalistic design in real-life clinical practice in patients with comorbidities and under multiple drug treatment regimens. African patients are often burdened with communicable and noncommunicable comorbidities, yet the application of pharmacogenomics in African clinical settings remains limited. Using warfarin as a model, this study aims at minimizing gaps in precision/personalized medicine research in African clinical practice. We present, therefore, pharmacogenomic profiles of a cohort of 503 black Africans (n = 252) and Mixed Ancestry (n = 251) patients from Southern Africa, on warfarin and co-prescribed drugs in a naturalized noncontrolled environment. Seventy-three (n = 73) single nucleotide polymorphisms (SNPs) in 29 pharmacogenes were characterized using a combination of allelic discrimination, Sanger sequencing, restriction fragment length polymorphism, and Sequenom Mass Array. The common comorbidities were hypertension (43-46%), heart failure (39-45%), diabetes mellitus (18%), arrhythmia (25%), and HIV infection (15%). Accordingly, the most common co-prescribed drugs were antihypertensives, antiarrhythmic drugs, antidiabetics, and antiretroviral therapy. We observed marked variation in major pharmacogenes both at interethnic levels and within African subpopulations. The Mixed Ancestry group presented a profile of genetic variants reflecting their European, Asian, and African admixture. Precision medicine requires that African populations begin to capture their own pharmacogenetic SNPs as they cannot always infer with absolute certainty from Asian and European populations. In the current historical moment of the COVID-19 pandemic, we also underscore that the spectrum of drugs interacting with warfarin will likely increase, given the systemic and cardiovascular effects of COVID-19, and the anticipated influx of COVID-19 medicines in the near future. This observational clinical pharmacogenomics study of warfarin, together with past precision medicine research, collectively, lends strong support for incorporation of pharmacogenetic profiling in clinical settings in African patients for effective and safe administration of therapeutics." @default.
- W4200126334 created "2021-12-31" @default.
- W4200126334 creator A5019372650 @default.
- W4200126334 creator A5025572938 @default.
- W4200126334 creator A5037462935 @default.
- W4200126334 creator A5047773727 @default.
- W4200126334 creator A5049897667 @default.
- W4200126334 creator A5051864508 @default.
- W4200126334 creator A5060539310 @default.
- W4200126334 creator A5068174607 @default.
- W4200126334 creator A5078491667 @default.
- W4200126334 creator A5082069854 @default.
- W4200126334 date "2022-01-01" @default.
- W4200126334 modified "2023-10-14" @default.
- W4200126334 title "Warfarin Pharmacogenomics for Precision Medicine in Real-Life Clinical Practice in Southern Africa: Harnessing 73 Variants in 29 Pharmacogenes" @default.
- W4200126334 cites W1034965150 @default.
- W4200126334 cites W1571654167 @default.
- W4200126334 cites W1604547439 @default.
- W4200126334 cites W1966629336 @default.
- W4200126334 cites W1968604782 @default.
- W4200126334 cites W1992700573 @default.
- W4200126334 cites W1997933847 @default.
- W4200126334 cites W2015488487 @default.
- W4200126334 cites W2016487973 @default.
- W4200126334 cites W2017294431 @default.
- W4200126334 cites W2017957939 @default.
- W4200126334 cites W2028938803 @default.
- W4200126334 cites W2030447006 @default.
- W4200126334 cites W2030978880 @default.
- W4200126334 cites W2034802701 @default.
- W4200126334 cites W2037424123 @default.
- W4200126334 cites W2039141364 @default.
- W4200126334 cites W2046601674 @default.
- W4200126334 cites W2047664536 @default.
- W4200126334 cites W2071240356 @default.
- W4200126334 cites W2079433867 @default.
- W4200126334 cites W2080228333 @default.
- W4200126334 cites W2086199174 @default.
- W4200126334 cites W2104930292 @default.
- W4200126334 cites W2105902511 @default.
- W4200126334 cites W2106437551 @default.
- W4200126334 cites W2107514091 @default.
- W4200126334 cites W2109989116 @default.
- W4200126334 cites W2110774735 @default.
- W4200126334 cites W2129316818 @default.
- W4200126334 cites W2137810975 @default.
- W4200126334 cites W2140026462 @default.
- W4200126334 cites W2141644324 @default.
- W4200126334 cites W2144360398 @default.
- W4200126334 cites W2147458465 @default.
- W4200126334 cites W2154598042 @default.
- W4200126334 cites W2163636261 @default.
- W4200126334 cites W2164036335 @default.
- W4200126334 cites W2166155891 @default.
- W4200126334 cites W2253998502 @default.
- W4200126334 cites W2323214475 @default.
- W4200126334 cites W2410566890 @default.
- W4200126334 cites W2473769014 @default.
- W4200126334 cites W2568539993 @default.
- W4200126334 cites W2570427206 @default.
- W4200126334 cites W2743241706 @default.
- W4200126334 cites W2746406130 @default.
- W4200126334 cites W2755126513 @default.
- W4200126334 cites W2759473504 @default.
- W4200126334 cites W2809353373 @default.
- W4200126334 cites W2887860572 @default.
- W4200126334 cites W2890393360 @default.
- W4200126334 cites W2921394945 @default.
- W4200126334 cites W2947498540 @default.
- W4200126334 cites W2953785565 @default.
- W4200126334 cites W2990794606 @default.
- W4200126334 cites W2995598335 @default.
- W4200126334 cites W3006013653 @default.
- W4200126334 cites W3008090866 @default.
- W4200126334 cites W3013933158 @default.
- W4200126334 cites W3042202739 @default.
- W4200126334 cites W3050041722 @default.
- W4200126334 cites W3133517424 @default.
- W4200126334 cites W3188935172 @default.
- W4200126334 cites W3209998873 @default.
- W4200126334 cites W2886190937 @default.
- W4200126334 cites W2905447261 @default.
- W4200126334 doi "https://doi.org/10.1089/omi.2021.0199" @default.
- W4200126334 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34958284" @default.
- W4200126334 hasPublicationYear "2022" @default.
- W4200126334 type Work @default.
- W4200126334 citedByCount "8" @default.
- W4200126334 countsByYear W42001263342022 @default.
- W4200126334 countsByYear W42001263342023 @default.
- W4200126334 crossrefType "journal-article" @default.
- W4200126334 hasAuthorship W4200126334A5019372650 @default.
- W4200126334 hasAuthorship W4200126334A5025572938 @default.
- W4200126334 hasAuthorship W4200126334A5037462935 @default.
- W4200126334 hasAuthorship W4200126334A5047773727 @default.
- W4200126334 hasAuthorship W4200126334A5049897667 @default.
- W4200126334 hasAuthorship W4200126334A5051864508 @default.
- W4200126334 hasAuthorship W4200126334A5060539310 @default.
- W4200126334 hasAuthorship W4200126334A5068174607 @default.